On November 7, Chen Junhui, Director of Intervention and Cell Therapy Center of Peking University Shenzhen Hospital, Professor Fan Daye, Director of Clinical Research Department Xu Yanwei, Chief physician of Health Management Center Wang Shaobin, Professor Wu Yalin of Ultrasound Intervention Department and other delegation visited Shenzhen Cell Valley. The company's chairman Shi Yuanyuan, chairman assistant Wei Zheng, General Office director Luan Zhishi, chief scientist assistant Li Pengfei warmly received and held the third preparatory meeting for the establishment of the Cell medicine Safety and Standards Professional Committee.

Cell Medicine Safety and Standards Professional Committee is approved by China Food and Drug Enterprise Quality and Safety Promotion Association, led by Peking University Shenzhen Hospital, Shenzhen Cell Valley and other enterprises jointly initiated the establishment of China Food and drug Enterprise Quality and Safety Promotion Association. This meeting is the third preparatory meeting for the establishment of the conference. Director Chen Junhui chaired the meeting and introduced the establishment background, purposes and objectives, organizational matrix of the Cell Medicine Safety and Standards Professional Committee in detail. Subsequently, the preparatory Group conducted in-depth discussions on the relevant preparatory work for the founding conference and made specific work arrangements. This preparation will lay a good foundation for the successful holding of the establishment conference of the Cell Medicine Safety and Standards Professional Committee, and further deepen the long-term cooperation between the two sides in the field of cell and gene therapy in the future.